Stockreport

Clearmind Medicine CEO Issues Letter to Shareholders

Clearmind Medicine Inc.  (CMND) 
PDF Vancouver, Canada, April 09, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq:CMND), (FSE: CWY0) (“Clearmind” or the “company”), a clinical-stage biotech comp [Read more]